id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6535-0002,FDA,FDA-2017-D-6535,Draft Guidance for Industry on Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research,Other,Guidance,2017-12-19T05:00:00Z,2017,12,2017-12-19T05:00:00Z,,2024-11-07T01:16:23Z,,1,0,0900006482d3bf1b
FDA-2017-D-6535-0001,FDA,FDA-2017-D-6535,"Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research; Draft Guidance for Industry and Food and Drug Administration 
Staff; Availability",Notice,Notice of Availability,2017-12-19T05:00:00Z,2017,12,2017-12-19T05:00:00Z,2018-03-20T03:59:59Z,2018-03-20T01:03:43Z,2017-27275,0,0,0900006482d3ac76